Designing molecular diagnostics for current tuberculosis drug regimens

Diagnostic development must occur in parallel with drug development to ensure the longevity of new treatment compounds. Despite an increasing number of novel and repurposed anti-tuberculosis compounds and regimens, there remains a large number of drugs for which no rapid and accurate molecular diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Georghiou, Sophia B., de Vos, Margaretha, Velen, Kavindhran, Miotto, Paolo, Colman, Rebecca E., Cirillo, Daniela Maria, Ismail, Nazir, Rodwell, Timothy C., Suresh, Anita, Ruhwald, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Tuberculosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980415/
https://www.ncbi.nlm.nih.gov/pubmed/36752055
http://dx.doi.org/10.1080/22221751.2023.2178243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980415/
https://www.ncbi.nlm.nih.gov/pubmed/36752055
http://dx.doi.org/10.1080/22221751.2023.2178243

Ejemplares similares